Recently, new studies have focused on the involvement of several proteins in the TLR7 signaling pathways (e.g., TLR7 and MyD88), which have been identified as potential therapeutic targets for the treatment of autoimmune diseases (49). Here, MYD88 is linked to autoimmune disease.